Viemed Healthcare, Inc.
Sembol: VMD
NASDAQ
9.38
USDBugünkü piyasa fiyatı
26.7260
F/K Oranı
0.0462
PEG Oranı
361.03M
MRK Kapağı
- 0.00%
DIV Verimi
Viemed Healthcare, Inc. (VMD) Finansal Tablolar
Bilanço
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 12.8 | 16.9 | 28.4 | ||||||||
balance-sheet.row.short-term-investments | 0 | 0 | -2 | 0 | ||||||||
balance-sheet.row.net-receivables | 0 | 18.4 | 15.4 | 14.7 | ||||||||
balance-sheet.row.inventory | 0 | 4.6 | 3.6 | 2.5 | ||||||||
balance-sheet.row.other-current-assets | 0 | 2.4 | 3.8 | 1.7 | ||||||||
balance-sheet.row.total-current-assets | 0 | 38.2 | 39.7 | 47.3 | ||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 76.5 | 68.4 | 62.8 | ||||||||
balance-sheet.row.goodwill | 0 | 29.6 | 0 | 0 | ||||||||
balance-sheet.row.intangible-assets | 0 | 0.6 | 0 | 0 | ||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 30.3 | 0 | 0 | ||||||||
balance-sheet.row.long-term-investments | 0 | 3.9 | 4.2 | 2.2 | ||||||||
balance-sheet.row.tax-assets | 0 | 4.5 | 3.1 | 4.8 | ||||||||
balance-sheet.row.other-non-current-assets | 0 | 0.7 | 1.6 | 0.9 | ||||||||
balance-sheet.row.total-non-current-assets | 0 | 115.9 | 77.3 | 70.7 | ||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-assets | 0 | 154.1 | 117 | 118 | ||||||||
balance-sheet.row.account-payables | 0 | 4.2 | 2.6 | 3.2 | ||||||||
balance-sheet.row.short-term-debt | 0 | 2 | 0.5 | 1.9 | ||||||||
balance-sheet.row.tax-payables | 0 | 2.1 | 0 | 0 | ||||||||
balance-sheet.row.long-term-debt-total | 0 | 6 | 0.2 | 4.6 | ||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||
balance-sheet.row.other-current-liab | 0 | 19.6 | 11.1 | 8.9 | ||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 8.8 | 1.1 | 5.3 | ||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.capital-lease-obligations | 0 | 2.3 | 0.7 | 0.7 | ||||||||
balance-sheet.row.total-liab | 0 | 40.8 | 19.9 | 23.1 | ||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0.3 | 0 | ||||||||
balance-sheet.row.common-stock | 0 | 18.6 | 15.1 | 14 | ||||||||
balance-sheet.row.retained-earnings | 0 | 79.1 | 69.8 | 73.3 | ||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | -0.3 | -0.3 | ||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 15.6 | 12.1 | 7.7 | ||||||||
balance-sheet.row.total-stockholders-equity | 0 | 113.3 | 97.1 | 94.8 | ||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 154.1 | 117 | 118 | ||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-equity | 0 | 113.3 | 97.1 | 94.8 | ||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||
Total Investments | 0 | 3.9 | 2.2 | 2.2 | ||||||||
balance-sheet.row.total-debt | 0 | 10.3 | 0.7 | 6.5 | ||||||||
balance-sheet.row.net-debt | 0 | -2.5 | -16.2 | -21.9 |
Nakit Akış Tablosu
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 10.4 | 6.2 | 9.1 | ||||||||
cash-flows.row.depreciation-and-amortization | 0 | 22.3 | 15.6 | 11.3 | ||||||||
cash-flows.row.deferred-income-tax | 0 | -1.5 | 1.7 | 3.9 | ||||||||
cash-flows.row.stock-based-compensation | 0 | 5.8 | 5.2 | 5.2 | ||||||||
cash-flows.row.change-in-working-capital | 0 | 7.9 | -10.1 | -13.6 | ||||||||
cash-flows.row.account-receivables | 0 | -1.1 | -12.6 | -7.3 | ||||||||
cash-flows.row.inventory | 0 | -0.5 | 0.3 | -0.2 | ||||||||
cash-flows.row.account-payables | 0 | -0.9 | -0.3 | 0.1 | ||||||||
cash-flows.row.other-working-capital | 0 | 10.4 | 2.4 | -6.1 | ||||||||
cash-flows.row.other-non-cash-items | 0 | 1 | 9.1 | 6.6 | ||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -26.6 | -22.9 | -19.7 | ||||||||
cash-flows.row.acquisitions-net | 0 | -26.5 | -0.1 | -0.6 | ||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -2 | -0.6 | ||||||||
cash-flows.row.sales-maturities-of-investments | 0 | -2.6 | 0 | 0.6 | ||||||||
cash-flows.row.other-investing-activites | 0 | 2.6 | 1.1 | 0.6 | ||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -53.1 | -24 | -19.7 | ||||||||
cash-flows.row.debt-repayment | 0 | -2.3 | -5.8 | -4 | ||||||||
cash-flows.row.common-stock-issued | 0 | 1.3 | 0.3 | 0.1 | ||||||||
cash-flows.row.common-stock-repurchased | 0 | -0.6 | -9.7 | -1.4 | ||||||||
cash-flows.row.dividends-paid | 0 | -0.4 | -0.3 | -0.1 | ||||||||
cash-flows.row.other-financing-activites | 0 | 4.9 | 0.3 | 0.1 | ||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 2.9 | -15.3 | -5.3 | ||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0.1 | 0 | 0 | ||||||||
cash-flows.row.net-change-in-cash | 0 | 6.9 | -11.5 | -2.6 | ||||||||
cash-flows.row.cash-at-end-of-period | 0 | 12.8 | 16.9 | 28.4 | ||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 5.9 | 28.4 | 31 | ||||||||
cash-flows.row.operating-cash-flow | 0 | 46 | 27.7 | 22.5 | ||||||||
cash-flows.row.capital-expenditure | 0 | -26.6 | -22.9 | -19.7 | ||||||||
cash-flows.row.free-cash-flow | 0 | 19.5 | 4.8 | 2.8 |
Gelir Tablosu Satırı
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 186.4 | 138.8 | 117.1 | ||||||||
income-statement-row.row.cost-of-revenue | 0 | 72.9 | 54.2 | 43.7 | ||||||||
income-statement-row.row.gross-profit | 0 | 113.4 | 84.7 | 73.4 | ||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.other-expenses | 0 | 0.1 | 0 | -0.8 | ||||||||
income-statement-row.row.operating-expenses | 0 | 97.6 | 76.1 | 61.4 | ||||||||
income-statement-row.row.cost-and-expenses | 0 | 170.6 | 130.2 | 105 | ||||||||
income-statement-row.row.interest-income | 0 | 0 | 0.2 | 0.3 | ||||||||
income-statement-row.row.interest-expense | 0 | 0.4 | 0.2 | 0.3 | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -1.1 | 0.7 | 0.9 | ||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||
income-statement-row.row.other-operating-expenses | 0 | 0.1 | 0 | -0.8 | ||||||||
income-statement-row.row.total-operating-expenses | 0 | -1.1 | 0.7 | 0.9 | ||||||||
income-statement-row.row.interest-expense | 0 | 0.4 | 0.2 | 0.3 | ||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 22.3 | 16.3 | 12.2 | ||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||
income-statement-row.row.operating-income | 0 | 15.8 | 8.3 | 11.6 | ||||||||
income-statement-row.row.income-before-tax | 0 | 14.7 | 9 | 12.5 | ||||||||
income-statement-row.row.income-tax-expense | 0 | 4.2 | 2.8 | 3.4 | ||||||||
income-statement-row.row.net-income | 0 | 10.2 | 6.2 | 9.1 |
Sıkça Sorulan Sorular
Nedir Viemed Healthcare, Inc. (VMD) toplam varlıklar?
Viemed Healthcare, Inc. (VMD) toplam varlıklar 154102510.000 şeklindedir.
İşletmenin yıllık geliri nedir?
Yıllık gelir N/A'dur.
Firma kâr marjı nedir?
Firma kar marjı 0.609'dir.
Şirket serbest nakit akışı nedir?
Serbest nakit akışı 0.228'dur.
İşletme net kar marjı nedir?
Net kâr marjı 0.053'dir.
Firma toplam geliri nedir?
Toplam gelir 0.077'dur.
Nedir Viemed Healthcare, Inc. (VMD) net kar (net gelir)?
Net kar (net gelir) 10243000.000'dur.
Firmanın toplam borcu nedir?
Toplam borç 10271179.000'dir.
Faaliyet giderleri rakamı nedir?
İşletme giderleri 97637306.000'dır.
Şirket nakit rakamı nedir?
İşletme içi nakit 0.000'tir.